Literature DB >> 11756767

Atypical fibrous histiocytoma of the skin: clinicopathologic analysis of 59 cases with evidence of infrequent metastasis.

Steven Kaddu1, Máirín E McMenamin, Christopher D M Fletcher.   

Abstract

Atypical fibrous histiocytoma is an uncommon, poorly documented variant of cutaneous fibrous histiocytoma. We studied 59 cases of atypical fibrous histiocytoma to better characterize the clinicopathologic spectrum. There were 33 males and 26 females (median age 38 years; range 5-79 years) with solitary lesions arising on lower (25 cases) and upper (17 cases) extremities, trunk (6 cases), head and neck (4 cases), and vulva (1 case); anatomic location was not stated in six cases. Lesions measured 0.4-8 cm in diameter (median 1.5 cm) and clinically were nodules (40 cases), polypoid tumors (18 cases), or a slightly elevated plaque (1 case). Histologically, the lesions were primarily dermal with superficial involvement of the subcutis in one third of the cases. Salient features included a proliferation of pleomorphic, plump, spindle, and/or polyhedral cells with mainly large, hyperchromatic, irregular, or bizarre nuclei, set in a background of classic features of fibrous histiocytoma, including spindle cell areas showing a storiform pattern and entrapped thickened, hyaline collagen bundles, especially at the periphery. Multinucleated giant cells, often with bizarre nuclei and foamy, sometimes hemosiderin-rich, cytoplasm were also variably present. The degree of pleomorphism varied from only focal and minimal (14 cases) or moderate (24 cases) to marked (21 cases). Mitotic activity was observed in 55 lesions, and the number of mitotic figures ranged from 1 to 15 per 10 high power fields. Atypical mitoses were noted in 20 lesions. Furthermore, some cases of atypical fibrous histiocytoma displayed other worrisome features less often observed in ordinary FH, including unusually large size (diameter >2 cm, 8 cases), involvement of the superficial subcutis (19 cases), and geographic necrosis (7 cases). Immunohistochemical studies performed in 42 cases showed only focal smooth muscle actin (10 cases) and CD34 (4 cases) positivity, whereas CD68, S-100 protein, desmin, pan-keratin, and epithelial membrane antigen were negative. Clinical follow-up data available in 21 patients (mean duration of follow-up 50.6 months, median 43 months) revealed local recurrences in three patients (one repeated); two patients developed distant metastases, one of whom died after 96 months. These two cases were not histologically distinct from the group as a whole. We conclude that atypical fibrous histiocytoma has a broader clinicopathologic spectrum than previously realized. Lesions with floridly atypical features represent potential pitfalls for overinterpretation as pleomorphic sarcoma, which would appear to be inappropriate in most cases. Provided that atypical fibrous histiocytoma is treated by complete excision, a benign outcome is to be expected in most cases. However, similar to the cellular and aneurysmal variants of fibrous histiocytoma, atypical fibrous histiocytoma shows a higher tendency to recur locally than ordinary fibrous histiocytoma and may rarely metastasize.

Entities:  

Mesh:

Year:  2002        PMID: 11756767     DOI: 10.1097/00000478-200201000-00004

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  14 in total

1.  Deep penetrating benign fibrous histiocytoma of the foot associated with throbbing pain.

Authors:  Jimin Chung; Sun Namkoong; Ji Hyun Sim; Joong Sun Lee; Seung Phil Hong; Myung Hwa Kim; Byung Cheol Park
Journal:  Ann Dermatol       Date:  2011-10-31       Impact factor: 1.444

2.  [A rare low-grade malignant scalp tumor. Atypical fibroxanthoma].

Authors:  A Stepanova; W C Marsch; V Stadie
Journal:  Hautarzt       Date:  2005-07       Impact factor: 0.751

3.  [Fibrohistiocytic tumors of the skin: a heterogeneous group of superficially located mesenchymal neoplasms].

Authors:  T Mentzel
Journal:  Pathologe       Date:  2015-02       Impact factor: 1.011

Review 4.  Angiosarcomas: histology, immunohistochemistry and molecular insights with implications for differential diagnosis.

Authors:  Isidro Machado; Francisco Giner; Javier Lavernia; Julia Cruz; Víctor Traves; Celia Requena; Beatriz Llombart; José Antonio López-Guerrero; Antonio Llombart-Bosch
Journal:  Histol Histopathol       Date:  2020-09-04       Impact factor: 2.303

5.  Gene fusion detection in formalin-fixed paraffin-embedded benign fibrous histiocytomas using fluorescence in situ hybridization and RNA sequencing.

Authors:  Charles Walther; Jakob Hofvander; Jenny Nilsson; Linda Magnusson; Henryk A Domanski; David Gisselsson; Johnbosco Tayebwa; Leona A Doyle; Christopher D M Fletcher; Fredrik Mertens
Journal:  Lab Invest       Date:  2015-06-29       Impact factor: 5.662

6.  [Benign cellular fibrous histiocytoma with erosion of the phalanx].

Authors:  H Kurzen; W Hartschuh
Journal:  Hautarzt       Date:  2003-01-15       Impact factor: 0.751

7.  Spectrum and Incidence of Skin Cancer among Individuals with Li-Fraumeni Syndrome.

Authors:  Jessica N Hatton; Michael R Sargen; Megan N Frone; Kelvin C de Andrade; Sharon A Savage; Payal P Khincha
Journal:  J Invest Dermatol       Date:  2022-02-17       Impact factor: 7.590

8.  Atypical cutaneous fibrous histiocytoma: an unusual and misleading variant of fibrous histiocytoma.

Authors:  Soumaya Ben Abdelkrim; Colondane Belajouza; Wafa Jomaa; Nadia Beizig; Zeineb Ben Said; Moncef Mokni; Rafia Nouira; Badreddine Sriha
Journal:  Case Rep Pathol       Date:  2011-07-14

9.  A Case of Cellular Fibrous Histiocytoma on the Right Elbow with Repeated Relapse within a Short Period.

Authors:  Kanako Tsunoda; Hiroki Oikawa; Fumihiko Maeda; Kazuhiro Takahashi; Toshihide Akasaka
Journal:  Case Rep Dermatol       Date:  2015-01-22

10.  Two different types of malignant fibrous histiocytomas from pet dogs.

Authors:  Sun Hee Do; Il Hwa Hong; Jin Kyu Park; Ae Ri Ji; Tae Hwan Kim; Dong Mi Kwak; Kyu Shik Jeong
Journal:  J Vet Sci       Date:  2009-06       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.